Navigation Links
Alma Lasers Announces FDA Clearance of the UniForm Handpiece
Date:1/26/2009

BUFFALO GROVE, Ill., Jan. 26 /PRNewswire/ -- Alma Lasers Ltd. ("Alma"), a leader in laser, light and radiofrequency-based aesthetic devices, announced today the FDA clearance and immediate availability of the UniForm handpiece. The UniForm is the fifth module available on the Accent(TM) XL radiofrequency device. The UniForm has received FDA clearance for "the temporary reduction in the appearance of cellulite."

The UniForm handpiece is comprised of Alma's propriety UniPolar technology for the delivery of RF therapeutic heat into the dermal and subdermal tissue, accompanied by a mechanical massager component. The mechanical component increases circulation in the subcutaneous tissues producing superior results.

"We are extremely excited to announce the FDA's clearance of the UniForm handpiece as it offers patients a consistent way to reduce cellulite with no downtime or discomfort," said Howard Kelly, CEO of Alma Lasers. "This most recent regulatory achievement allows us to continue offering innovative and effective solutions for all physicians while furthering Alma's success in the aesthetics industry."

The UniForm handpiece incorporates Alma Lasers' IN-Motion Technology that ensures the session is easy, fast and comfortable. IN-Motion Technology gradually heats the layers of skin to the target therapeutic temperature, so there is no risk of injury to the patient and allowing the procedure to be virtually pain-free.

"We have been extremely happy with the Accent(TM) XL system. Our patients have been very satisfied with the consistent results they are seeing and the fact that the treatments are fast and comfortable is an added bonus," says Karen Harkaway, M.D., Board Certified Dermatologist. "Of all the RF systems on the market, I feel the Accent(TM) XL offers the widest breadth of treatment options and the most consistent results."


'/>"/>
SOURCE Alma Lasers Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Axsun Technologies Announces Exclusive Cardiac Supply Agreement for Advanced OCT Tunable Lasers with LightLab Imaging
2. Alma Lasers Announces FDA Clearance of the Harmony(XL) Multi-Application System at THE Aesthetic Show 2008
3. Lumenis Sues Alma Lasers and its 4 founders for 200 Million Shekels
4. Alma(TM) Lasers to Debut Five New Products at the 66th Annual Meeting of the American Academy of Dermatology
5. Alma Lasers Announces Proposed Initial Public Offering
6. Alma Lasers Answers Lumenis Complaint
7. SpectraScience Announces Business Update
8. AMDL, Inc. Chairman & CEO Announces Expert Opinion on Chinas Economic Forecast
9. NEC Foundation of America Announces New Grants
10. Authentidate Announces Termination of Merger Agreement With Parascript, LLC
11. Neovasc Announces Agreement With LeMaitre Vascular for Exclusive Distribution Rights to its Biological Vascular Strips
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: